Based on the Surrozen Inc stock forecast from 2 analysts, the average analyst target price for Surrozen Inc is USD 32.00 over the next 12 months. Surrozen Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Surrozen Inc is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Surrozen Inc’s stock price was USD 8.35. Surrozen Inc’s stock price has changed by -16.16% over the past week, -7.22% over the past month and -19.71% over the last year.
No recent analyst target price found for Surrozen Inc
No recent average analyst rating found for Surrozen Inc
Company Overview Surrozen Inc
Surrozen, Inc., a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. The company is developing antibody-based therapeutics which targets various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043, a hepatocyte-specific R-spondin mimetic bispecific fusion protein, which is in Phase 1b clinical trial for the treatment of severe liver diseases, including alcohol-associated hepatitis. The company develops SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies. Surrozen, Inc. is based in South San Francisco, California. Read Less
Surrozen, Inc., a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. The company is developing antibody-based therapeutics which targets various disease areas, including diseases of the intestine...Read More
Frequently Asked Questions About Surrozen Inc (SRZN) Stock
Based on ratings from 2 analysts Surrozen Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 3 buy, sell and hold ratings.
Unfortunately we do not have enough data on SRZN's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for SRZN is USD 32.00 over the next 12 months. The maximum analyst target price is USD 32 while the minimum anlayst target price is USD 32.
Unfortunately we do not have enough data on SRZN's stock to indicate if its overvalued.
The last closing price of SRZN's stock was USD 8.35.
The most recent market capitalization for SRZN is USD 0.08B.
Based on targets from 2 analysts, the average taret price for SRZN is projected at USD 32.00 over the next 12 months.
This means that SRZN's stock price may go up by +283.23% over the next 12 months.
We can't find any ETFs which contains Surrozen Inc's stock.
As per our most recent records Surrozen Inc has 42 Employees.
Surrozen Inc's registered address is 171 Oyster Point Boulevard, South San Francisco, CA, United States, 94080.
You can get more information about it from Surrozen Inc's website at https://www.surrozen.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Surrozen Inc (SRZN) Stock
Based on ratings from 2 analysts Surrozen Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 3 buy, sell and hold ratings.
Unfortunately we do not have enough data on SRZN's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for SRZN is USD 32.00 over the next 12 months. The maximum analyst target price is USD 32 while the minimum anlayst target price is USD 32.
Unfortunately we do not have enough data on SRZN's stock to indicate if its overvalued.
The last closing price of SRZN's stock was USD 8.35.
The most recent market capitalization for SRZN is USD 0.08B.
Based on targets from 2 analysts, the average taret price for SRZN is projected at USD 32.00 over the next 12 months.
This means that SRZN's stock price may go up by +283.23% over the next 12 months.
We can't find any ETFs which contains Surrozen Inc's stock.
As per our most recent records Surrozen Inc has 42 Employees.
Surrozen Inc's registered address is 171 Oyster Point Boulevard, South San Francisco, CA, United States, 94080.
You can get more information about it from Surrozen Inc's website at https://www.surrozen.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SRZN !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
